110 related articles for article (PubMed ID: 8345163)
1. Fluoxetine's spectrum of action in premenstrual syndrome.
Menkes DB; Taghavi E; Mason PA; Howard RC
Int Clin Psychopharmacol; 1993; 8(2):95-102. PubMed ID: 8345163
[TBL] [Abstract][Full Text] [Related]
2. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.
Miner C; Brown E; McCray S; Gonzales J; Wohlreich M
Clin Ther; 2002 Mar; 24(3):417-33. PubMed ID: 11952025
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine in the treatment of premenstrual syndrome.
Stone AB; Pearlstein TB; Brown WA
Psychopharmacol Bull; 1990; 26(3):331-5. PubMed ID: 2274633
[TBL] [Abstract][Full Text] [Related]
4. Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study.
Wood SH; Mortola JF; Chan YF; Moossazadeh F; Yen SS
Obstet Gynecol; 1992 Sep; 80(3 Pt 1):339-44. PubMed ID: 1495689
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine in the treatment of premenstrual syndrome.
Ozeren S; Corakçi A; Yücesoy I; Mercan R; Erhan G
Eur J Obstet Gynecol Reprod Biol; 1997 Jun; 73(2):167-70. PubMed ID: 9228499
[TBL] [Abstract][Full Text] [Related]
6. Low doses of fluoxetine for the treatment of emotional premenstrual syndrome: a randomized double-blind, placebo-controlled, pilot study.
Maranho MCMF; Guapo VG; de Rezende MG; Vieira CS; Brandão ML; Graeff FG; Lovick T; Del-Ben CM
Psychoneuroendocrinology; 2023 Nov; 157():106360. PubMed ID: 37572412
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.
Steiner M; Steinberg S; Stewart D; Carter D; Berger C; Reid R; Grover D; Streiner D
N Engl J Med; 1995 Jun; 332(23):1529-34. PubMed ID: 7739706
[TBL] [Abstract][Full Text] [Related]
8. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
Stewart DE; Fairman M; Barbadoro S; Zownir P; Steiner M
Biol Psychiatry; 1994 Aug; 36(3):201-2. PubMed ID: 7948458
[No Abstract] [Full Text] [Related]
9. Fluoxetine in the treatment of premenstrual dysphoria.
Su TP; Schmidt PJ; Danaceau MA; Tobin MB; Rosenstein DL; Murphy DL; Rubinow DR
Neuropsychopharmacology; 1997 May; 16(5):346-56. PubMed ID: 9109106
[TBL] [Abstract][Full Text] [Related]
10. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.
Cohen LS; Miner C; Brown EW; Freeman E; Halbreich U; Sundell K; McCray S
Obstet Gynecol; 2002 Sep; 100(3):435-44. PubMed ID: 12220761
[TBL] [Abstract][Full Text] [Related]
11. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
Romano S; Judge R; Dillon J; Shuler C; Sundell K
Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
[TBL] [Abstract][Full Text] [Related]
12. Open trial of fluoxetine therapy for premenstrual syndrome.
Elks ML
South Med J; 1993 May; 86(5):503-7. PubMed ID: 8488394
[TBL] [Abstract][Full Text] [Related]
13. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
[TBL] [Abstract][Full Text] [Related]
14. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Halbreich U; Smoller JW
J Clin Psychiatry; 1997 Sep; 58(9):399-402. PubMed ID: 9378691
[TBL] [Abstract][Full Text] [Related]
15. Long-term fluoxetine treatment of late luteal phase dysphoric disorder.
Pearlstein TB; Stone AB
J Clin Psychiatry; 1994 Aug; 55(8):332-5. PubMed ID: 8071300
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
[TBL] [Abstract][Full Text] [Related]
17. Rapid response to fluoxetine in women with premenstrual dysphoric disorder.
Steinberg EM; Cardoso GM; Martinez PE; Rubinow DR; Schmidt PJ
Depress Anxiety; 2012 Jun; 29(6):531-40. PubMed ID: 22565858
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine in the treatment of late luteal phase dysphoric disorder.
Stone AB; Pearlstein TB; Brown WA
J Clin Psychiatry; 1991 Jul; 52(7):290-3. PubMed ID: 2071558
[TBL] [Abstract][Full Text] [Related]
19. Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder.
Pearlstein TB; Stone AB; Lund SA; Scheft H; Zlotnick C; Brown WA
J Clin Psychopharmacol; 1997 Aug; 17(4):261-6. PubMed ID: 9241004
[TBL] [Abstract][Full Text] [Related]
20. Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study.
Jermain DM; Preece CK; Sykes RL; Kuehl TJ; Sulak PJ
Arch Fam Med; 1999; 8(4):328-32. PubMed ID: 10418540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
